Publicis picks up Sanofi vaccines PR

Share this article:
Sanofi Pasteur has handed the communications business on several key vaccines, including the prospective launch of Pentacel, to Publicis Public Relations.

The move, first reported in PRWeek, follows a three-month, four-way review. Pentacel and Adacel will be handled jointly by Publicis' MS&L and Publicis Consultants PR.

Five-in-one Pentacel, which protects against tetanus, diphtheria, pertussis, polio and flu in children, got the green light from an FDA advisory panel in January, and is expected to win approval this month. The vaccine would mean fewer shots for infants and children under 18 months—from the current 23 to 18.

“We believe the marketplace is interested in combination vaccines because of all the vaccines on children's schedules,” Sanofi Pasteur PR manager Susan Watkins told PRWeek. “We are looking forward to hearing from the FDA, and Publicis will be helping us along the way.”

Adacel, approved in 2005, protects adults and adolescents against tetanus, diphtheria and pertussis.
While infants are particularly vulnerable to pertussis—commonly called whooping cough— cases have been on the rise among adolescents and adults in recent years, with infections occurring as childhood immunizations wear off.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?